| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Wnt receptor activity | 8.60e-05 | 17 | 103 | 3 | GO:0042813 | |
| GeneOntologyMolecularFunction | I-SMAD binding | 8.60e-05 | 17 | 103 | 3 | GO:0070411 | |
| GeneOntologyBiologicalProcess | kidney epithelium development | 1.71e-05 | 162 | 103 | 7 | GO:0072073 | |
| GeneOntologyCellularComponent | heteromeric SMAD protein complex | 6.58e-06 | 8 | 104 | 3 | GO:0071144 | |
| GeneOntologyCellularComponent | SMAD protein complex | 1.40e-05 | 10 | 104 | 3 | GO:0071141 | |
| Domain | FRI | 3.95e-06 | 20 | 103 | 4 | SM00063 | |
| Domain | - | 4.86e-06 | 21 | 103 | 4 | 1.10.2000.10 | |
| Domain | Frizzled_dom | 8.51e-06 | 24 | 103 | 4 | IPR020067 | |
| Domain | FZ | 8.51e-06 | 24 | 103 | 4 | PS50038 | |
| Domain | Fz | 8.51e-06 | 24 | 103 | 4 | PF01392 | |
| Domain | DWB | 8.94e-06 | 8 | 103 | 3 | SM00524 | |
| Domain | MH2 | 8.94e-06 | 8 | 103 | 3 | PS51076 | |
| Domain | MH1 | 8.94e-06 | 8 | 103 | 3 | PS51075 | |
| Domain | - | 8.94e-06 | 8 | 103 | 3 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 8.94e-06 | 8 | 103 | 3 | IPR013019 | |
| Domain | Dwarfin | 8.94e-06 | 8 | 103 | 3 | IPR013790 | |
| Domain | MH2 | 8.94e-06 | 8 | 103 | 3 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 8.94e-06 | 8 | 103 | 3 | IPR001132 | |
| Domain | Frizzled | 2.60e-05 | 11 | 103 | 3 | IPR000539 | |
| Domain | Frizzled | 2.60e-05 | 11 | 103 | 3 | PF01534 | |
| Domain | DHR-1_domain | 2.60e-05 | 11 | 103 | 3 | IPR027007 | |
| Domain | DHR_2 | 2.60e-05 | 11 | 103 | 3 | PS51651 | |
| Domain | DHR_1 | 2.60e-05 | 11 | 103 | 3 | PS51650 | |
| Domain | DHR-2 | 2.60e-05 | 11 | 103 | 3 | PF06920 | |
| Domain | DOCK | 2.60e-05 | 11 | 103 | 3 | IPR026791 | |
| Domain | DOCK_C | 2.60e-05 | 11 | 103 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 2.60e-05 | 11 | 103 | 3 | PF14429 | |
| Domain | DHR-2 | 2.60e-05 | 11 | 103 | 3 | IPR027357 | |
| Domain | Frizzled | 2.60e-05 | 11 | 103 | 3 | SM01330 | |
| Domain | MAD_homology1_Dwarfin-type | 3.46e-05 | 12 | 103 | 3 | IPR003619 | |
| Domain | DWA | 3.46e-05 | 12 | 103 | 3 | SM00523 | |
| Domain | MH1 | 3.46e-05 | 12 | 103 | 3 | PF03165 | |
| Domain | SMAD_dom-like | 8.66e-05 | 16 | 103 | 3 | IPR017855 | |
| Domain | - | 8.66e-05 | 16 | 103 | 3 | 2.60.200.10 | |
| Domain | Frizzled/SFRP | 8.66e-05 | 16 | 103 | 3 | IPR015526 | |
| Domain | SUMO_chordates | 9.00e-05 | 3 | 103 | 2 | IPR027218 | |
| Domain | Sumo | 1.79e-04 | 4 | 103 | 2 | IPR033950 | |
| Domain | Rad60-SLD | 2.98e-04 | 5 | 103 | 2 | PF11976 | |
| Domain | Rad60/SUMO-like_dom | 2.98e-04 | 5 | 103 | 2 | IPR022617 | |
| Domain | DUF3398 | 4.45e-04 | 6 | 103 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 4.45e-04 | 6 | 103 | 2 | IPR021816 | |
| Domain | ARM-type_fold | 5.78e-04 | 339 | 103 | 8 | IPR016024 | |
| Domain | ARM-like | 7.43e-04 | 270 | 103 | 7 | IPR011989 | |
| Domain | MKP | 1.32e-03 | 10 | 103 | 2 | IPR008343 | |
| Domain | SMAD_FHA_domain | 2.96e-03 | 52 | 103 | 3 | IPR008984 | |
| Domain | DUF1605 | 3.88e-03 | 17 | 103 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 3.88e-03 | 17 | 103 | 2 | PF07717 | |
| Domain | HA2 | 4.35e-03 | 18 | 103 | 2 | SM00847 | |
| Domain | HA2 | 4.35e-03 | 18 | 103 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 4.35e-03 | 18 | 103 | 2 | IPR007502 | |
| Domain | GPCR_2_secretin-like | 4.44e-03 | 60 | 103 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 4.44e-03 | 60 | 103 | 3 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 4.65e-03 | 61 | 103 | 3 | PS50261 | |
| Pathway | WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING | 3.28e-06 | 108 | 83 | 7 | M48078 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 5.91e-06 | 118 | 83 | 7 | M39852 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 2.05e-05 | 28 | 83 | 4 | MM15042 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 2.72e-05 | 30 | 83 | 4 | M27323 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 6.14e-05 | 116 | 83 | 6 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 6.45e-05 | 117 | 83 | 6 | M39530 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4 | 6.84e-05 | 14 | 83 | 3 | M47834 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY | 1.04e-04 | 16 | 83 | 3 | M47823 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 1.27e-04 | 44 | 83 | 4 | MM15878 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO | 1.78e-04 | 19 | 83 | 3 | M47833 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 1.95e-04 | 143 | 83 | 6 | M39591 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 2.63e-04 | 53 | 83 | 4 | MM15880 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 2.81e-04 | 153 | 83 | 6 | M39546 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 3.03e-04 | 55 | 83 | 4 | M39351 | |
| Pathway | REACTOME_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1 | 3.39e-04 | 5 | 83 | 2 | M27223 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 3.97e-04 | 59 | 83 | 4 | M39886 | |
| Pathway | BIOCARTA_SUMO_PATHWAY | 5.06e-04 | 6 | 83 | 2 | M22055 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY | 5.06e-04 | 6 | 83 | 2 | M47624 | |
| Pathway | REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED | 5.06e-04 | 6 | 83 | 2 | M27225 | |
| Pathway | PID_WNT_SIGNALING_PATHWAY | 5.80e-04 | 28 | 83 | 3 | M77 | |
| Pathway | BIOCARTA_SUMO_PATHWAY | 7.06e-04 | 7 | 83 | 2 | MM1570 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY | 7.06e-04 | 7 | 83 | 2 | M47845 | |
| Pathway | REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED | 7.06e-04 | 7 | 83 | 2 | MM14928 | |
| Pathway | REACTOME_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9 | 7.06e-04 | 7 | 83 | 2 | M27224 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY | 9.37e-04 | 8 | 83 | 2 | M47847 | |
| Pathway | WP_ENDOTHELIN_PATHWAYS | 9.45e-04 | 33 | 83 | 3 | M39651 | |
| Pubmed | GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways. | 1.01e-08 | 9 | 106 | 4 | 24932701 | |
| Pubmed | 1.44e-07 | 16 | 106 | 4 | 21939397 | ||
| Pubmed | 2.74e-07 | 5 | 106 | 3 | 25141865 | ||
| Pubmed | Fgf9 signaling regulates small intestinal elongation and mesenchymal development. | 3.80e-07 | 20 | 106 | 4 | 18653563 | |
| Pubmed | RAB23 coordinates early osteogenesis by repressing FGF10-pERK1/2 and GLI1. | 3.80e-07 | 20 | 106 | 4 | 32662771 | |
| Pubmed | 4.69e-07 | 21 | 106 | 4 | 17065231 | ||
| Pubmed | 5.47e-07 | 6 | 106 | 3 | 21518886 | ||
| Pubmed | Smad7 is required for the development and function of the heart. | 5.47e-07 | 6 | 106 | 3 | 18952608 | |
| Pubmed | 5.47e-07 | 6 | 106 | 3 | 11850197 | ||
| Pubmed | 9.55e-07 | 7 | 106 | 3 | 15009097 | ||
| Pubmed | Negative regulation of BMP/Smad signaling by Tob in osteoblasts. | 9.55e-07 | 7 | 106 | 3 | 11163184 | |
| Pubmed | 9.55e-07 | 7 | 106 | 3 | 15376321 | ||
| Pubmed | A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. | 1.52e-06 | 8 | 106 | 3 | 19211612 | |
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 10647776 | ||
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 23804438 | ||
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 10708949 | ||
| Pubmed | BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. | 1.58e-06 | 28 | 106 | 4 | 19224984 | |
| Pubmed | Identification of novel Smad2 and Smad3 associated proteins in response to TGF-beta1. | 1.71e-06 | 65 | 106 | 5 | 18729074 | |
| Pubmed | 2.28e-06 | 9 | 106 | 3 | 19018011 | ||
| Pubmed | 2.28e-06 | 9 | 106 | 3 | 9759503 | ||
| Pubmed | 2.28e-06 | 9 | 106 | 3 | 30134160 | ||
| Pubmed | 2.28e-06 | 9 | 106 | 3 | 15993878 | ||
| Pubmed | 2.28e-06 | 9 | 106 | 3 | 24816837 | ||
| Pubmed | Tgf-beta3-induced palatal fusion is mediated by Alk-5/Smad pathway. | 2.28e-06 | 9 | 106 | 3 | 14729481 | |
| Pubmed | 2.28e-06 | 9 | 106 | 3 | 20007998 | ||
| Pubmed | Dullard/Ctdnep1 regulates endochondral ossification via suppression of TGF-β signaling. | 2.28e-06 | 9 | 106 | 3 | 25155999 | |
| Pubmed | 2.28e-06 | 9 | 106 | 3 | 10708948 | ||
| Pubmed | The non-canonical BMP and Wnt/β-catenin signaling pathways orchestrate early tooth development. | 2.74e-06 | 32 | 106 | 4 | 25428587 | |
| Pubmed | TGF-β signaling inhibits canonical BMP signaling pathway during palate development. | 3.25e-06 | 10 | 106 | 3 | 29247325 | |
| Pubmed | 3.25e-06 | 10 | 106 | 3 | 23620745 | ||
| Pubmed | Protein Arginine Methyltransferase PRMT1 Is Essential for Palatogenesis. | 3.25e-06 | 10 | 106 | 3 | 29986157 | |
| Pubmed | Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. | 3.25e-06 | 10 | 106 | 3 | 9436979 | |
| Pubmed | Expression of Frizzled genes in developing and postnatal hair follicles. | 3.25e-06 | 10 | 106 | 3 | 15245425 | |
| Pubmed | Essential roles of mesenchyme-derived beta-catenin in mouse Müllerian duct morphogenesis. | 3.25e-06 | 10 | 106 | 3 | 17532316 | |
| Pubmed | BORCS6 PDXDC1 SNX4 LAMTOR2 ECE1 BLOC1S2 RUFY3 ARFGEF3 VPS13B SMAD2 | 3.44e-06 | 504 | 106 | 10 | 34432599 | |
| Pubmed | Frizzled-9 impairs acetylcholine receptor clustering in skeletal muscle cells. | 4.46e-06 | 11 | 106 | 3 | 24860427 | |
| Pubmed | Molecular determinants of WNT9b responsiveness in nephron progenitor cells. | 4.46e-06 | 11 | 106 | 3 | 30978219 | |
| Pubmed | 4.46e-06 | 11 | 106 | 3 | 17576136 | ||
| Pubmed | Ectopic Activation of Fgf8 in Dental Mesenchyme Causes Incisor Agenesis and Molar Microdontia. | 4.46e-06 | 11 | 106 | 3 | 39000154 | |
| Pubmed | 4.46e-06 | 11 | 106 | 3 | 17582687 | ||
| Pubmed | Smad2 and Smad3 Regulate Chondrocyte Proliferation and Differentiation in the Growth Plate. | 4.46e-06 | 11 | 106 | 3 | 27741240 | |
| Pubmed | 4.46e-06 | 11 | 106 | 3 | 24008158 | ||
| Pubmed | Smad7-induced beta-catenin degradation alters epidermal appendage development. | 4.46e-06 | 11 | 106 | 3 | 16950122 | |
| Pubmed | 4.98e-06 | 37 | 106 | 4 | 23592779 | ||
| Pubmed | 5.93e-06 | 12 | 106 | 3 | 21538804 | ||
| Pubmed | Connexin 40, a target of transcription factor Tbx5, patterns wrist, digits, and sternum. | 5.93e-06 | 12 | 106 | 3 | 15923624 | |
| Pubmed | 5.93e-06 | 12 | 106 | 3 | 14656760 | ||
| Pubmed | 5.93e-06 | 12 | 106 | 3 | 17460146 | ||
| Pubmed | 5.93e-06 | 12 | 106 | 3 | 30664861 | ||
| Pubmed | Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. | 7.70e-06 | 13 | 106 | 3 | 16959237 | |
| Pubmed | Enhanced BMP signaling results in supernumerary tooth formation in USAG-1 deficient mouse. | 7.70e-06 | 13 | 106 | 3 | 18329379 | |
| Pubmed | Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation. | 7.70e-06 | 13 | 106 | 3 | 23530056 | |
| Pubmed | Endoglin is required for myogenic differentiation potential of neural crest stem cells. | 7.70e-06 | 13 | 106 | 3 | 17628518 | |
| Pubmed | 8.64e-06 | 560 | 106 | 10 | 35241646 | ||
| Pubmed | Estrogen receptor-α signaling increases allergen-induced IL-33 release and airway inflammation. | 9.20e-06 | 2 | 106 | 2 | 32648964 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25202020 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 30334368 | ||
| Pubmed | PRMT3 inhibits ubiquitination of ribosomal protein S2 and together forms an active enzyme complex. | 9.20e-06 | 2 | 106 | 2 | 18573314 | |
| Pubmed | STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection. | 9.20e-06 | 2 | 106 | 2 | 28576981 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 28751448 | ||
| Pubmed | Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. | 9.20e-06 | 2 | 106 | 2 | 10692421 | |
| Pubmed | Genetic variation in physiological sensitivity to estrogen in mice. | 9.20e-06 | 2 | 106 | 2 | 11478683 | |
| Pubmed | The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle. | 9.20e-06 | 2 | 106 | 2 | 18565875 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19635839 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 36932155 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 28447741 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19010908 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 32530114 | ||
| Pubmed | Augmentation of estrogen receptor-mediated transcription by steroid and xenobiotic receptor. | 9.20e-06 | 2 | 106 | 2 | 19011999 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21291420 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20189955 | ||
| Pubmed | Identification of a putative RNA helicase (HRH1), a human homolog of yeast Prp22. | 9.20e-06 | 2 | 106 | 2 | 7935475 | |
| Pubmed | Ribosomal protein S2 is a substrate for mammalian PRMT3 (protein arginine methyltransferase 3). | 9.20e-06 | 2 | 106 | 2 | 15473865 | |
| Pubmed | Ribosomal protein rpS2 is hypomethylated in PRMT3-deficient mice. | 9.20e-06 | 2 | 106 | 2 | 17439947 | |
| Pubmed | SUMO2 and SUMO3 redundantly prevent a noncanonical type I interferon response. | 9.20e-06 | 2 | 106 | 2 | 29891701 | |
| Pubmed | Characterization of promoter of the tuberculosis-resistant gene intracellular pathogen resistance 1. | 9.20e-06 | 2 | 106 | 2 | 26590945 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25047847 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22306003 | ||
| Pubmed | Matrix GLA protein, an inhibitory morphogen in pulmonary vascular development. | 9.77e-06 | 14 | 106 | 3 | 17670744 | |
| Pubmed | 9.77e-06 | 14 | 106 | 3 | 38951500 | ||
| Pubmed | Loss of Smad4 in the scleraxis cell lineage results in postnatal joint contracture. | 9.77e-06 | 14 | 106 | 3 | 33248111 | |
| Pubmed | 9.77e-06 | 14 | 106 | 3 | 16790475 | ||
| Pubmed | 9.77e-06 | 14 | 106 | 3 | 23238123 | ||
| Pubmed | 9.77e-06 | 14 | 106 | 3 | 25274628 | ||
| Pubmed | 9.77e-06 | 14 | 106 | 3 | 12432077 | ||
| Pubmed | 9.77e-06 | 14 | 106 | 3 | 20847311 | ||
| Pubmed | 9.77e-06 | 14 | 106 | 3 | 16435884 | ||
| Pubmed | Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease. | 1.06e-05 | 94 | 106 | 5 | 20346360 | |
| Pubmed | 1.22e-05 | 15 | 106 | 3 | 23011393 | ||
| Pubmed | Constitutively active mutation of ACVR1 in oral epithelium causes submucous cleft palate in mice. | 1.22e-05 | 15 | 106 | 3 | 26116174 | |
| Pubmed | 1.22e-05 | 15 | 106 | 3 | 23946498 | ||
| Pubmed | MBTD1 ESR1 DUSP5 CPT1A ECE1 RUFY3 FZD1 FZD8 PPP1R10 MBNL2 SV2B FGFR1 FZD2 | 1.22e-05 | 1006 | 106 | 13 | 15226823 | |
| Pubmed | 1.43e-05 | 48 | 106 | 4 | 27703004 | ||
| Pubmed | SENP3-regulated Nodal signaling plays a potential role in cardiac left-right asymmetry development. | 1.50e-05 | 16 | 106 | 3 | 38925188 | |
| Pubmed | Dynamic signaling network for the specification of embryonic pancreas and liver progenitors. | 1.50e-05 | 16 | 106 | 3 | 19556507 | |
| Pubmed | SMAD4 is essential for generating subtypes of neurons during cerebellar development. | 1.81e-05 | 17 | 106 | 3 | 22370000 | |
| Pubmed | Disrupted tenogenesis in masseter as a potential cause of micrognathia. | 1.81e-05 | 17 | 106 | 3 | 36257937 | |
| Pubmed | 1.81e-05 | 17 | 106 | 3 | 18832393 | ||
| Pubmed | Smad7 regulates terminal maturation of chondrocytes in the growth plate. | 1.81e-05 | 17 | 106 | 3 | 23994637 | |
| Pubmed | Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families. | 1.81e-05 | 17 | 106 | 3 | 28733458 | |
| GeneFamily | SMAD family | 4.77e-06 | 8 | 81 | 3 | 750 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 1.39e-05 | 11 | 81 | 3 | 286 | |
| GeneFamily | Biogenesis of lysosomal organelles complex 1 |BLOC-1 related complex | 5.45e-04 | 8 | 81 | 2 | 1048 | |
| GeneFamily | MAP kinase phosphatases | 1.06e-03 | 11 | 81 | 2 | 895 | |
| GeneFamily | DEAH-box helicases | 2.28e-03 | 16 | 81 | 2 | 500 | |
| Coexpression | GU_PDEF_TARGETS_UP | 4.39e-07 | 71 | 106 | 6 | M3955 | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_1-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.96e-07 | 194 | 105 | 7 | f0467d81063a9b19783906c456935ef8318b9b98 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.99e-06 | 157 | 105 | 6 | 7ceae5fe00c91d4feb8c314d3a31f027c03fa56f | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-06 | 186 | 105 | 6 | 9d6cb36aa0aae69fe584dad31deafcfdcc9fd1db | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.44e-06 | 187 | 105 | 6 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-06 | 188 | 105 | 6 | c74771584b3ba9561a99a54bf55a9203ddf8eff8 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-06 | 188 | 105 | 6 | 9155b9a92496e75646778c025b02947e9e9ec73a | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-06 | 192 | 105 | 6 | f094ac378e635cf5820e8a8b7a0152073a51ceae | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-06 | 193 | 105 | 6 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | droplet-Lung-21m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.52e-06 | 193 | 105 | 6 | 3a5ad8ffad441e30a6e1bd017da7720ad57f6c57 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 6.72e-06 | 194 | 105 | 6 | b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-06 | 195 | 105 | 6 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.92e-06 | 195 | 105 | 6 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 | |
| ToppCell | ASK452-Epithelial-Type_1|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.33e-06 | 197 | 105 | 6 | dc0a6dca4af6b216357b06f67203274f8b2a8bb0 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.33e-06 | 197 | 105 | 6 | 3fe665c0277d091290b63f0dd24c0c6536a45309 | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.55e-06 | 198 | 105 | 6 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | proximal-Epithelial-Alveolar_Epithelial_Type_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.99e-06 | 200 | 105 | 6 | b652bc73adfdeccbdcd74497ab6e2085e5c95e88 | |
| ToppCell | proximal-Epithelial-Alveolar_Epithelial_Type_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.99e-06 | 200 | 105 | 6 | c1345893e6947ccf9b41282d0e4428dbfb8bcc27 | |
| ToppCell | proximal-3-Epithelial-Alveolar_Epithelial_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.99e-06 | 200 | 105 | 6 | 51f8fc43c069f2c4e75588d28ae6deb5d7ed2c86 | |
| ToppCell | Club_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.76e-05 | 159 | 105 | 5 | a7bcff268b1962a561fd2848e01ae16565bce895 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.99e-05 | 161 | 105 | 5 | 7c9d4410d7142a5f3a05418c994f69978c9ffa17 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 161 | 105 | 5 | b9a63fc9becc44d305fc7c221283bf59ec06b10f | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-05 | 169 | 105 | 5 | 8a6d05b5d60b2b2e43a8ff7521feb79cd6dbd940 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-05 | 172 | 105 | 5 | ce444463f69bbb05c933615a0f1f43ddde3eee1c | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-05 | 172 | 105 | 5 | 2c993a93ac91dcf6061eec001f51f8cccb6ee264 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-05 | 172 | 105 | 5 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-05 | 172 | 105 | 5 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 175 | 105 | 5 | 9a96794df049d8228fea57c1584c160191d36b56 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.93e-05 | 175 | 105 | 5 | 6a093c74a6f3daeff07759d6eec542fc5c709149 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 6.09e-05 | 176 | 105 | 5 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.43e-05 | 178 | 105 | 5 | 9d575902d3dbe33437c9d4200df093a741269803 | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-05 | 179 | 105 | 5 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 6.60e-05 | 179 | 105 | 5 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | frontal_cortex-Non-neuronal|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.60e-05 | 179 | 105 | 5 | ef01478bd03eb00f0ff2b6a8ae9244687c5f85aa | |
| ToppCell | AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.95e-05 | 181 | 105 | 5 | ed0ea67f0607073aedf153f8d1073b35e46127c3 | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 7.51e-05 | 184 | 105 | 5 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-05 | 185 | 105 | 5 | efcfbf5a48b3ea9a425183e5c2eec6a9585415a0 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-05 | 185 | 105 | 5 | 642088ace9230d38b0579853c54ff4dd8b5d5df4 | |
| ToppCell | ASK454-Epithelial-Type_1|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.32e-05 | 188 | 105 | 5 | 13f8ce8f24ac7d7ed87f4ae3b8f4096de29383c2 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-05 | 189 | 105 | 5 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.53e-05 | 189 | 105 | 5 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.74e-05 | 190 | 105 | 5 | 52213cd2a6a20772d4f49ba9ac0407abafa528db | |
| ToppCell | Control-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 8.96e-05 | 191 | 105 | 5 | 11dfd8f38beb294f42710cfbd355cb089e1023c0 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.96e-05 | 191 | 105 | 5 | a15e34ad7dbf3f2f13d5e23ce3ffb6d08fd1f9f0 | |
| ToppCell | facs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 191 | 105 | 5 | ae524103331fa53fa82888dbb567fc36abcee7e0 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.96e-05 | 191 | 105 | 5 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.96e-05 | 191 | 105 | 5 | 40e617d3c93f03ae87baf6c0b2304b617f5fe782 | |
| ToppCell | facs-Lung-Endomucin_-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-05 | 192 | 105 | 5 | ba3fe97786564dba1c8185f2802ce1b57f4f3cc9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.18e-05 | 192 | 105 | 5 | 1b0138fd0bfdee266325751f8b2d163d91a71bf5 | |
| ToppCell | droplet-Lung-1m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.18e-05 | 192 | 105 | 5 | ff435141329e3e29fa9b08a4d5b2f55074e7f9ab | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.18e-05 | 192 | 105 | 5 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | facs-Lung-Endomucin_|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-05 | 192 | 105 | 5 | 85d4d0df701451daf95e94a87a0096da1e86533b | |
| ToppCell | Endothelial-Endothelial-B|Endothelial / shred on cell class and cell subclass (v4) | 9.18e-05 | 192 | 105 | 5 | f8d7bd81e031d09a557722627c2f6180811cc6ab | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 193 | 105 | 5 | 2218833749576ba1a0fc95bd155c781e7e1163c6 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 193 | 105 | 5 | ffdcbc5caff7fd4cc2e83dd21a05d43b0593d542 | |
| ToppCell | CF-Epithelial|CF / Disease state, Lineage and Cell class | 9.41e-05 | 193 | 105 | 5 | 518901c2e36a79c6189cd0d9e6d36dbd4f56a79c | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.41e-05 | 193 | 105 | 5 | bd0027fa97de41ae22ff64a61c8e217496f122ca | |
| ToppCell | droplet-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.41e-05 | 193 | 105 | 5 | 25129080f8a40b2988a5d9dfec36ff9e72c27e61 | |
| ToppCell | CF-Epithelial-Epithelial_cell|CF / Disease state, Lineage and Cell class | 9.41e-05 | 193 | 105 | 5 | 4e3dda27c71b7fdac90d081f0d8e9ca3a8ea7820 | |
| ToppCell | droplet-Lung-1m-Endothelial-capillary_endothelial-capillary_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.64e-05 | 194 | 105 | 5 | e13923860a64ba9cf32df53c9f0cf4e7c321881d | |
| ToppCell | CTRL-Myeloid-Monocyte_Macrophage|Myeloid / Disease state, Lineage and Cell class | 9.64e-05 | 194 | 105 | 5 | 73459ee062ae1f1a3bb9719dc0b89aae10600e22 | |
| ToppCell | CTRL-Epithelial-Epithelial_cell|CTRL / Disease state, Lineage and Cell class | 9.64e-05 | 194 | 105 | 5 | 2bc4deaf2a01a39809fc323962fce4286835209c | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-05 | 194 | 105 | 5 | 68efc6df31479839a3bd5fe9fbc98ddceecc3b10 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-05 | 194 | 105 | 5 | df56e23f1dcf1902d29392fcc947e0e268e1648b | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.64e-05 | 194 | 105 | 5 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.64e-05 | 194 | 105 | 5 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | distal-1-Hematologic-Myeloid_Dendritic_Type_1|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.64e-05 | 194 | 105 | 5 | 85a4be291c25ad1fb14199b87d822cf47d748fc0 | |
| ToppCell | CTRL-Epithelial|CTRL / Disease state, Lineage and Cell class | 9.64e-05 | 194 | 105 | 5 | 49dcb31427f370692308f939e23992925708abb7 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-05 | 194 | 105 | 5 | 03985e4ab10f140f758e70dc7bfaa059b4e3bb18 | |
| ToppCell | droplet-Lung-1m-Endothelial-capillary_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.64e-05 | 194 | 105 | 5 | 86508dd9b9d345b6624d185048cc92b81dd11c2a | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 9.87e-05 | 195 | 105 | 5 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | ASK428|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.87e-05 | 195 | 105 | 5 | 41cbd7ea0bfab2db338b4ba0fc67cb3ae0d63d6d | |
| ToppCell | normal_Lung-Epithelial_cells-AT1|normal_Lung / Location, Cell class and cell subclass | 9.87e-05 | 195 | 105 | 5 | 569d1ebc5a5aa110a2430b096755ae35354040c4 | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 9.87e-05 | 195 | 105 | 5 | 78978d85273e5463a7f43e4c121e647fa6aba42b | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 196 | 105 | 5 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.01e-04 | 196 | 105 | 5 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.01e-04 | 196 | 105 | 5 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 196 | 105 | 5 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.01e-04 | 196 | 105 | 5 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.01e-04 | 196 | 105 | 5 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.01e-04 | 196 | 105 | 5 | 97e16d9833e4083d719ca7058d5fc9b11edb37e3 | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-04 | 197 | 105 | 5 | 5bd2f32137fd849931e52093d630d2e7e27daf4f | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-04 | 197 | 105 | 5 | d9baa0be469fd8737a74b5078d30ce7d66759160 | |
| ToppCell | medial-2-Hematologic-Myeloid_Dendritic_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-04 | 197 | 105 | 5 | 3c1147857de6a7ab6b0cf77f5a6364d4c8669693 | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.04e-04 | 197 | 105 | 5 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | BAL-Mild-cDC_10|Mild / Compartment, Disease Groups and Clusters | 1.04e-04 | 197 | 105 | 5 | c0550d41dd5619b369b590f3d6a61154dd7b2cab | |
| ToppCell | ASK440-Epithelial-Type_1|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.04e-04 | 197 | 105 | 5 | 1eda2c2504451a3d626dda5c2b2b12eeaa6bca54 | |
| ToppCell | ASK440-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.04e-04 | 197 | 105 | 5 | 782449c522c9e16e72bf999a73090688a3aefe06 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.06e-04 | 198 | 105 | 5 | 59214e34b077dffa989c48635fdef143f57f1320 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.06e-04 | 198 | 105 | 5 | a3d4b6e4259ded2193d94d2ff6d48cf67214fc35 | |
| ToppCell | moderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.06e-04 | 198 | 105 | 5 | 7d96d7105a849c7280ce87bd76ce130ac47384fd | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.06e-04 | 198 | 105 | 5 | 7f7024b26337ae2bc7f57c3274a7dfdaaa64ab7c | |
| ToppCell | medial-2-Epithelial-Alveolar_Epithelial_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.09e-04 | 199 | 105 | 5 | 456460c761e26ed4b1d88d9bee4d2a7c9bd9d416 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 199 | 105 | 5 | ce699726ac4825c65bf934cb9a76202ad7340596 | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.09e-04 | 199 | 105 | 5 | 5263338242f95c04690d0795749ccc20b0d19f7a | |
| ToppCell | IPF-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 1.09e-04 | 199 | 105 | 5 | 3c2b362d5e824e1a04830e70352f8818de984174 | |
| ToppCell | ASK452-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.09e-04 | 199 | 105 | 5 | 48cafe44951908d03f3c6f3e185e9cbb86fb5b3b | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-04 | 199 | 105 | 5 | 7b3d4c62b11268c7c1599600d8a7b331287cf21a | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.09e-04 | 199 | 105 | 5 | c11365653c69a5dfb37946231f8af05149a61a71 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.11e-04 | 200 | 105 | 5 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | distal-2-Epithelial-Alveolar_Epithelial_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.11e-04 | 200 | 105 | 5 | 313ec1e53bd738a9cb48dc5b946261156f99f44b | |
| Drug | Naringin hydrate [11032-30-7]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 3.31e-07 | 195 | 106 | 9 | 3286_DN | |
| Drug | Prenylamine lactate [69-43-2]; Up 200; 9.6uM; HL60; HG-U133A | 2.40e-06 | 184 | 106 | 8 | 1737_UP | |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; HL60; HT_HG-U133A | 3.17e-06 | 191 | 106 | 8 | 2937_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; HL60; HT_HG-U133A | 3.42e-06 | 193 | 106 | 8 | 2477_DN | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; PC3; HT_HG-U133A | 4.13e-06 | 198 | 106 | 8 | 2057_UP | |
| Drug | Bromperidol [10457-90-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 4.29e-06 | 199 | 106 | 8 | 2872_DN | |
| Drug | benidipine | 7.17e-06 | 27 | 106 | 4 | ctd:C061004 | |
| Drug | octamethylcyclotetrasiloxane | 2.15e-05 | 2 | 106 | 2 | ctd:C024064 | |
| Drug | Ethinyl Estradiol | 2.15e-05 | 2 | 106 | 2 | DB00977 | |
| Drug | Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 2.96e-05 | 189 | 106 | 7 | 4672_UP | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.96e-05 | 189 | 106 | 7 | 5254_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 3.28e-05 | 192 | 106 | 7 | 4743_DN | |
| Drug | Triprolidine hydrochloride [550-70-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.39e-05 | 193 | 106 | 7 | 7008_DN | |
| Drug | Clorsulon [60200-06-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.62e-05 | 195 | 106 | 7 | 2884_DN | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; HL60; HT_HG-U133A | 3.74e-05 | 196 | 106 | 7 | 3032_DN | |
| Drug | Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 3.74e-05 | 196 | 106 | 7 | 3302_DN | |
| Drug | Edrophonium chloride [116-38-1]; Up 200; 19.8uM; PC3; HT_HG-U133A | 3.74e-05 | 196 | 106 | 7 | 6655_UP | |
| Drug | U-62066 [87151-85-7]; Up 200; 1uM; MCF7; HT_HG-U133A | 3.99e-05 | 198 | 106 | 7 | 4375_UP | |
| Drug | Laudanosine (R,S) [1699-51-0]; Up 200; 11.2uM; PC3; HT_HG-U133A | 3.99e-05 | 198 | 106 | 7 | 7270_UP | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; HL60; HT_HG-U133A | 3.99e-05 | 198 | 106 | 7 | 2961_DN | |
| Drug | cyanophenphos | 6.42e-05 | 3 | 106 | 2 | ctd:C002488 | |
| Drug | Estradiol | 6.42e-05 | 3 | 106 | 2 | DB00783 | |
| Drug | AC1L9M5J | 7.97e-05 | 221 | 106 | 7 | CID000448615 | |
| Drug | enterodiol | 9.00e-05 | 19 | 106 | 3 | CID000115089 | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.08e-04 | 161 | 106 | 6 | 5022_UP | |
| Drug | chloropropylate | 1.28e-04 | 4 | 106 | 2 | ctd:C004663 | |
| Drug | ethyl bromophos | 1.28e-04 | 4 | 106 | 2 | ctd:C041062 | |
| Drug | Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester | 1.28e-04 | 4 | 106 | 2 | ctd:D004849 | |
| Drug | isofenphos | 1.28e-04 | 4 | 106 | 2 | ctd:C035019 | |
| Drug | dichlofenthion | 1.28e-04 | 4 | 106 | 2 | ctd:C011445 | |
| Drug | Pimozide [2062-78-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.28e-04 | 166 | 106 | 6 | 6780_UP | |
| Drug | Prestwick_517 | 1.39e-04 | 106 | 106 | 5 | CID000003804 | |
| Drug | Tritolyl Phosphates | 1.42e-04 | 22 | 106 | 3 | ctd:D014317 | |
| Drug | MG-262; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.61e-04 | 173 | 106 | 6 | 7068_DN | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.88e-04 | 178 | 106 | 6 | 5234_UP | |
| Drug | chlorobenzilate | 2.13e-04 | 5 | 106 | 2 | ctd:C004659 | |
| Drug | tolclofos-methyl | 2.13e-04 | 5 | 106 | 2 | ctd:C426783 | |
| Drug | flucythrinate | 2.13e-04 | 5 | 106 | 2 | ctd:C027975 | |
| Drug | schisandrol | 2.13e-04 | 5 | 106 | 2 | CID005321168 | |
| Drug | ethion | 2.13e-04 | 5 | 106 | 2 | ctd:C100038 | |
| Drug | isoprothiolane | 2.13e-04 | 5 | 106 | 2 | ctd:C023889 | |
| Drug | prothiophos | 2.13e-04 | 5 | 106 | 2 | ctd:C032072 | |
| Drug | TRAM 34 | 2.13e-04 | 5 | 106 | 2 | ctd:C411671 | |
| Drug | Leptophos | 2.13e-04 | 5 | 106 | 2 | ctd:D010773 | |
| Drug | Hexetidine [141-94-6]; Up 200; 11.8uM; HL60; HT_HG-U133A | 2.31e-04 | 185 | 106 | 6 | 2457_UP | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.52e-04 | 188 | 106 | 6 | 6451_DN | |
| Drug | triphenyl phosphate | 2.58e-04 | 121 | 106 | 5 | ctd:C005445 | |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.67e-04 | 190 | 106 | 6 | 5271_DN | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 2.67e-04 | 190 | 106 | 6 | 6769_DN | |
| Drug | 3,4,3',4'-tetrachlorobiphenyl | 2.70e-04 | 453 | 106 | 9 | ctd:C028451 | |
| Drug | Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; PC3; HT_HG-U133A | 2.74e-04 | 191 | 106 | 6 | 6693_UP | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 2.74e-04 | 191 | 106 | 6 | 5327_UP | |
| Drug | Hymecromone [90-33-5]; Down 200; 22.8uM; PC3; HT_HG-U133A | 2.90e-04 | 193 | 106 | 6 | 4623_DN | |
| Drug | Prednicarbate [73771-04-7]; Down 200; 8.2uM; PC3; HT_HG-U133A | 2.90e-04 | 193 | 106 | 6 | 5119_DN | |
| Drug | felodipine; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.90e-04 | 193 | 106 | 6 | 965_DN | |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A | 2.98e-04 | 194 | 106 | 6 | 5268_DN | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; PC3; HT_HG-U133A | 2.98e-04 | 194 | 106 | 6 | 5909_UP | |
| Drug | Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.98e-04 | 194 | 106 | 6 | 2864_DN | |
| Drug | Danazol [17230-88-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.06e-04 | 195 | 106 | 6 | 5315_DN | |
| Drug | Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 3.06e-04 | 195 | 106 | 6 | 2826_DN | |
| Drug | Thiamphenicol [15318-45-3]; Down 200; 11.2uM; HL60; HT_HG-U133A | 3.06e-04 | 195 | 106 | 6 | 1867_DN | |
| Drug | Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.06e-04 | 195 | 106 | 6 | 1523_DN | |
| Drug | Ofloxacin [82419-36-1]; Down 200; 11uM; HL60; HT_HG-U133A | 3.06e-04 | 195 | 106 | 6 | 2340_DN | |
| Drug | Sulfapyridine [144-83-2]; Down 200; 16uM; MCF7; HT_HG-U133A | 3.06e-04 | 195 | 106 | 6 | 6799_DN | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A | 3.06e-04 | 195 | 106 | 6 | 4991_UP | |
| Drug | Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 3.06e-04 | 195 | 106 | 6 | 7426_DN | |
| Drug | 0198306-0000 [212631-61-3]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.06e-04 | 195 | 106 | 6 | 7099_DN | |
| Drug | Cloxacillin sodium salt [642-78-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | 3.06e-04 | 195 | 106 | 6 | 2126_UP | |
| Drug | beta-hexachlorocyclohexane | 3.11e-04 | 126 | 106 | 5 | ctd:C023888 | |
| Drug | Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.15e-04 | 196 | 106 | 6 | 5615_DN | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.15e-04 | 196 | 106 | 6 | 4063_DN | |
| Drug | Acetazolamide [59-66-5]; Up 200; 18uM; MCF7; HT_HG-U133A | 3.15e-04 | 196 | 106 | 6 | 1686_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 3.15e-04 | 196 | 106 | 6 | 1181_UP | |
| Drug | Citalopram hydrobromide [59729-32-7]; Up 200; 1uM; PC3; HT_HG-U133A | 3.15e-04 | 196 | 106 | 6 | 3820_UP | |
| Drug | Meropenem [96036-03-2]; Down 200; 10.4uM; HL60; HT_HG-U133A | 3.15e-04 | 196 | 106 | 6 | 6141_DN | |
| Drug | ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 3.15e-04 | 196 | 106 | 6 | 918_UP | |
| Drug | Etilefrine hydrochloride [534-87-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 3.15e-04 | 196 | 106 | 6 | 4415_UP | |
| Drug | Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 3.15e-04 | 196 | 106 | 6 | 5081_DN | |
| Drug | Lysergol [602-85-7]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 3.15e-04 | 196 | 106 | 6 | 3261_UP | |
| Drug | Y-27632; Down 200; 3uM; MCF7; HT_HG-U133A_EA | 3.15e-04 | 196 | 106 | 6 | 832_DN | |
| Drug | flutolanil | 3.18e-04 | 6 | 106 | 2 | ctd:C475882 | |
| Drug | isopropyl 4,4'-dibromobenzilate | 3.18e-04 | 6 | 106 | 2 | ctd:C038267 | |
| Drug | Danazol | 3.18e-04 | 6 | 106 | 2 | DB01406 | |
| Drug | testololactone | 3.18e-04 | 6 | 106 | 2 | CID000160753 | |
| Drug | R)-3-pyrrolidinecarboxylic acid | 3.18e-04 | 6 | 106 | 2 | CID001501969 | |
| Drug | Loracarbef [121961-22-6]; Down 200; 10.8uM; HL60; HT_HG-U133A | 3.24e-04 | 197 | 106 | 6 | 2970_DN | |
| Drug | Domperidone maleate; Down 200; 7.4uM; PC3; HT_HG-U133A | 3.24e-04 | 197 | 106 | 6 | 4640_DN | |
| Drug | Fendiline hydrochloride [13636-18-5]; Down 200; 11.4uM; HL60; HG-U133A | 3.24e-04 | 197 | 106 | 6 | 1573_DN | |
| Drug | Dydrogesterone [152-62-5]; Up 200; 12.8uM; HL60; HT_HG-U133A | 3.24e-04 | 197 | 106 | 6 | 2156_UP | |
| Drug | Lisinopril [83915-83-7]; Up 200; 9uM; HL60; HT_HG-U133A | 3.24e-04 | 197 | 106 | 6 | 2371_UP | |
| Drug | nifedipine; Down 200; 10uM; MCF7; HG-U133A | 3.24e-04 | 197 | 106 | 6 | 335_DN | |
| Drug | Flufenamic acid [530-78-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 3.24e-04 | 197 | 106 | 6 | 2267_UP | |
| Drug | Podophyllotoxin [518-28-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.24e-04 | 197 | 106 | 6 | 6103_DN | |
| Drug | Furazolidone [67-45-8]; Down 200; 17.8uM; HL60; HT_HG-U133A | 3.24e-04 | 197 | 106 | 6 | 3019_DN | |
| Drug | Roxarsone [121-19-7]; Up 200; 15.2uM; PC3; HT_HG-U133A | 3.24e-04 | 197 | 106 | 6 | 5051_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A | 3.24e-04 | 197 | 106 | 6 | 6974_DN | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Down 200; 5.6uM; MCF7; HT_HG-U133A | 3.33e-04 | 198 | 106 | 6 | 7034_DN | |
| Drug | Ald1.1-H_000455; Down 200; 10uM; MCF7; HT_HG-U133A | 3.33e-04 | 198 | 106 | 6 | 7542_DN | |
| Drug | Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; PC3; HT_HG-U133A | 3.33e-04 | 198 | 106 | 6 | 4492_UP | |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; HL60; HT_HG-U133A | 3.33e-04 | 198 | 106 | 6 | 3081_DN | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 8.37e-06 | 12 | 101 | 3 | DOID:3319 (is_marker_for) | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 1.09e-05 | 13 | 101 | 3 | EFO_0800547 | |
| Disease | Hypophosphatemia | 3.47e-05 | 3 | 101 | 2 | C0085682 | |
| Disease | QRS duration, response to sulfonylurea | 6.56e-05 | 23 | 101 | 3 | EFO_0005055, EFO_0007922 | |
| Disease | Malignant neoplasm of breast | ESR1 CPT1A SP110 PKDREJ STAT1 EDNRB SURF1 DDX18 CST6 ZNF432 UQCC1 FGFR1 VPS13B | 7.70e-05 | 1074 | 101 | 13 | C0006142 |
| Disease | breast carcinoma (is_marker_for) | 7.92e-05 | 66 | 101 | 4 | DOID:3459 (is_marker_for) | |
| Disease | response to bronchodilator, response to corticosteroid | 1.15e-04 | 5 | 101 | 2 | GO_0031960, GO_0097366 | |
| Disease | Aganglionic megacolon | 1.72e-04 | 6 | 101 | 2 | cv:C0019569 | |
| Disease | glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement | 2.41e-04 | 7 | 101 | 2 | EFO_0800551 | |
| Disease | X-18899 measurement | 2.41e-04 | 7 | 101 | 2 | EFO_0800793 | |
| Disease | cortical surface area change measurement | 3.20e-04 | 8 | 101 | 2 | EFO_0021503 | |
| Disease | phenylacetylglutamine measurement | 7.49e-04 | 12 | 101 | 2 | EFO_0021013 | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 8.51e-04 | 54 | 101 | 3 | DOID:6432 (implicated_via_orthology) | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 8.83e-04 | 13 | 101 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | ecosanoids measurement | 8.97e-04 | 55 | 101 | 3 | EFO_0020044 | |
| Disease | Manganese Poisoning | 1.03e-03 | 14 | 101 | 2 | C0677050 | |
| Disease | asthma (biomarker_via_orthology) | 1.10e-03 | 59 | 101 | 3 | DOID:2841 (biomarker_via_orthology) | |
| Disease | Aganglionosis, Colonic | 1.18e-03 | 15 | 101 | 2 | C0085758 | |
| Disease | Aganglionosis, Rectosigmoid Colon | 1.18e-03 | 15 | 101 | 2 | C1257840 | |
| Disease | urolithiasis | 1.33e-03 | 63 | 101 | 3 | MONDO_0024647 | |
| Disease | Congenital Intestinal Aganglionosis | 1.53e-03 | 17 | 101 | 2 | C3661523 | |
| Disease | alcoholic hepatitis (biomarker_via_orthology) | 1.71e-03 | 18 | 101 | 2 | DOID:12351 (biomarker_via_orthology) | |
| Disease | metabolonic lactone sulfate measurement | 1.91e-03 | 19 | 101 | 2 | EFO_0800659 | |
| Disease | temporal horn of lateral ventricle volume measurement | 1.96e-03 | 72 | 101 | 3 | EFO_0010333 | |
| Disease | Craniofacial Abnormalities | 2.06e-03 | 156 | 101 | 4 | C0376634 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.17e-03 | 264 | 101 | 5 | EFO_0008317, EFO_0020944 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 2.26e-03 | 160 | 101 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 2.33e-03 | 21 | 101 | 2 | EFO_0022262 | |
| Disease | JT interval, response to sulfonylurea | 2.80e-03 | 23 | 101 | 2 | EFO_0007885, EFO_0007922 | |
| Disease | serum alanine aminotransferase measurement | 2.99e-03 | 869 | 101 | 9 | EFO_0004735 | |
| Disease | Cerebral Astrocytoma | 3.31e-03 | 25 | 101 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 3.31e-03 | 25 | 101 | 2 | C0750936 | |
| Disease | Astrocytoma | 3.31e-03 | 25 | 101 | 2 | C0004114 | |
| Disease | breast carcinoma (is_implicated_in) | 3.31e-03 | 25 | 101 | 2 | DOID:3459 (is_implicated_in) | |
| Disease | Grade I Astrocytoma | 3.31e-03 | 25 | 101 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 3.31e-03 | 25 | 101 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 3.31e-03 | 25 | 101 | 2 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 3.31e-03 | 25 | 101 | 2 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 3.31e-03 | 25 | 101 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 3.31e-03 | 25 | 101 | 2 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 3.31e-03 | 25 | 101 | 2 | C0338070 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CRDMFSKMATYLTGE | 41 | Q6QNY1 | |
| KMMESYIAVLTKGIC | 121 | Q6NSW5 | |
| CLILRMLYSFMKKGQ | 321 | Q9HA82 | |
| CLKYLVLANMLMKSG | 276 | P61201 | |
| TMKVRSGRYDCKTTM | 811 | Q9NXG0 | |
| VESVMKLCLIMAKYS | 701 | Q5JQC9 | |
| DMGKFCLTYEASMTR | 581 | P50416 | |
| FFYTLMTCEMLRKKS | 291 | P24530 | |
| KMYKSGYNTMEKCIE | 1701 | A6QL64 | |
| CSSAKTILKYMTDGM | 226 | O43143 | |
| MKTLTLSRYICEMTL | 1276 | Q8WWL7 | |
| KLMLFLSVTMCLSEY | 6 | O94779 | |
| EFEKCLTMRDTMKYV | 276 | P16260 | |
| AMLKPMCETLTYISK | 1341 | O94822 | |
| MGVCYFITARTLMKM | 216 | Q9NPB9 | |
| SVEMLRCRTASYMKK | 166 | Q7L8S5 | |
| GMQLRCYEMEKRLKT | 376 | Q6ZMT4 | |
| MCGMVGVRDAFYSKT | 56 | Q05BQ5 | |
| KIFSICVMLIGSLMY | 641 | Q9NS40 | |
| AGRFCMLKKEYMESF | 511 | Q9HCG8 | |
| KGSMAMESAKETRYC | 171 | P03372 | |
| EMIYSMCKKVLTGVA | 716 | O95373 | |
| EYKSMKSCLYVGMAS | 566 | Q6P996 | |
| GTKKEGCTILFMMLY | 321 | Q14332 | |
| FVQYKIMFSCSMKSS | 61 | Q969J5 | |
| MSTYMFKGIISFAKV | 246 | O75469 | |
| KKLMVFFSSCMSVKY | 426 | Q9NVP1 | |
| SRYIRVETCMFMIKL | 3956 | Q9Y4D8 | |
| LCFYKTAKDCVMMFT | 681 | P18084 | |
| GTKKEGCTILFMMLY | 396 | Q9UP38 | |
| FMLKYFMCLVVGITS | 586 | Q9H461 | |
| ACTFISGMMYLILRK | 151 | P54851 | |
| DFKMCYKLTSVVMEK | 246 | Q13042 | |
| YLKSCFSREPMMATV | 1296 | P42858 | |
| LMLTCMYTGKEKVSP | 2921 | P42858 | |
| AKEVCPMYFMKLRSG | 36 | O95760 | |
| VDMSIKGMYTLLARC | 311 | Q96GS4 | |
| KRCFTFMDRGYVFKM | 1061 | Q96BY6 | |
| KYGDMRVTMGCEIFS | 1036 | Q8N1I0 | |
| KSLLMCFLYILKSMS | 1301 | Q9BZ29 | |
| VYGFKMSCMKKAVIP | 386 | O60678 | |
| VKMRFYKDFLCTMDG | 161 | Q6ZN84 | |
| LISCMVGSVIVYKMK | 386 | P11362 | |
| YKSVIINTSKEMMCF | 56 | P49326 | |
| DLTMVRKIGCYAAMK | 406 | Q9H2C0 | |
| ATSYIMCLMKFVKGL | 1351 | Q5TH69 | |
| FVKMMALRAKCQGYV | 2096 | A8TX70 | |
| LATMCGGKMLDKLRY | 136 | O60941 | |
| QSYFDMKTITTRMIC | 956 | Q9Y5Q5 | |
| MKTITTRMICAGYES | 961 | Q9Y5Q5 | |
| RMCYLTIKEMATISE | 86 | Q9UBF2 | |
| FIKYCTMTEKAKIMS | 686 | Q0VDD8 | |
| TVCMDYIKGRCMREK | 216 | Q5VZF2 | |
| LCMYAKETVGFGMLK | 91 | Q9Y2Q5 | |
| KYFLTMEMGSTDCRK | 86 | Q15828 | |
| GKMTYLTMCIKESFR | 361 | P13584 | |
| KFMEVMYGTKKTCLP | 416 | P42892 | |
| TKRKCETSNMMEYVI | 196 | Q5VXU3 | |
| KMMESYIAVLTKGIC | 121 | Q8TCE6 | |
| RSATICLAYLMMKKR | 286 | Q13115 | |
| SLKRIAVGMFFVMCS | 401 | Q8N697 | |
| PTICMAYLMKTKQFR | 271 | Q16690 | |
| LKMNRCLKYATMAFG | 471 | O14772 | |
| TVIKYMTDGMLLREC | 656 | Q14562 | |
| YRTARNIMSMCFSKE | 826 | Q92833 | |
| RRETVKSALMVMYSC | 771 | A6NES4 | |
| MKMASTRCKLARYLE | 1 | Q96P20 | |
| AAMETIYLCKFRVSM | 21 | Q7L099 | |
| MESCELITYLGAKMT | 1866 | Q5TCS8 | |
| ALISYAVMQISMCKK | 421 | O95219 | |
| RKSIPLKMCYVTRSM | 241 | Q13884 | |
| MSMIIYSCLKEERKI | 101 | P42224 | |
| VTFSKLMRRMCGFYS | 511 | O60522 | |
| LMRRMCGFYSSASKL | 516 | O60522 | |
| YTDTKMILFMVSGIC | 221 | Q96DU3 | |
| CLSSSKKGMLGMIVY | 141 | Q7L1I2 | |
| EVCSKMFYRKDVMLD | 856 | P57071 | |
| EAMTYLCRKLRTMFS | 2191 | Q9NTG1 | |
| CRTLMFLKLMATYSA | 26 | Q96P88 | |
| TKDMRKSQERSMSYC | 126 | Q6P435 | |
| FAVCLVGFMLYRMKK | 266 | P18827 | |
| EKCMSMRKSYPNTLR | 471 | Q9BXF9 | |
| KVRGCFDHSKELYMM | 121 | Q15526 | |
| GYMVLLRCMKSEEKS | 531 | P46721 | |
| SIITKRMYMESLEAC | 41 | Q9HB58 | |
| KCRLQTMYEMETSGK | 131 | Q9Y619 | |
| MSKTLCIRMTTGAFK | 136 | A6NMS3 | |
| YELTKMCTIRMSFVK | 406 | O15198 | |
| EAVYELTKMCTIRMS | 401 | Q99717 | |
| RMMCAKGYSKKDFSS | 311 | P31937 | |
| KLMKAYCERQGLSMR | 41 | P55854 | |
| MGRYSGKTCRLLFML | 1 | Q6XR72 | |
| YQLTRMCTIRMSFVK | 406 | Q15796 | |
| SKLMKAYCERQGLSM | 41 | P61956 | |
| KKTMSTDEGTYMCIA | 281 | Q9HCK4 | |
| MCLVRMKQEGRSGKY | 156 | Q9NVA1 | |
| MKQEGRSGKYMCRII | 161 | Q9NVA1 | |
| KGKVMASMFYEVSTR | 1961 | P27708 | |
| ECRMYMTESFKIKTA | 636 | Q9H6N6 | |
| MVKKMCQDYLSSSGL | 411 | A8K0R7 | |
| ISLMTYSCMALSKSK | 1846 | Q7Z7G8 | |
| FMCSECGKGFTMKRY | 541 | O94892 | |
| EIRGTLKMMCESFIY | 116 | Q6UWM9 | |
| SYMCSECGKGFTMKR | 286 | Q8N883 | |
| RLCIDLSMTHYMSKK | 126 | Q6PF06 | |
| LKSNTEKFYMLCLMT | 336 | Q9H9Y6 | |
| EKFYMLCLMTRKLFA | 341 | Q9H9Y6 | |
| KKLLMMAGIDDCYTS | 211 | P15880 | |
| SLMKEARKMVSRCTY | 36 | Q96QC0 | |
| IYSMPGYKCSIKERM | 256 | Q6IBS0 | |
| GQMVKLKYCFTCKMF | 186 | Q9NUE0 | |
| MKKYRKISIGCFAMA | 1 | A6NCI4 |